相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Direct oral anticoagulants: a review on the current role and scope of reversal agents
Rahul Chaudhary et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma
Chi Zhang et al.
THROMBOSIS RESEARCH (2018)
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation
Saartje Bloemen et al.
THROMBOSIS RESEARCH (2018)
A review of commercially available thrombin generation assays
Jeremy Kintigh et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Measuring dabigatran with the dilute Russell viper venom confirm assay in an anticoagulation clinic population
David L. McGlasson et al.
BLOOD COAGULATION & FIBRINOLYSIS (2016)
Dabigatran Concentration: Variability and Potential Bleeding Prediction In Real-Life Patients With Atrial Fibrillationl
Petra Sinigoj et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders
M. Jacquemin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
Stephan Glund et al.
LANCET (2015)
The application of thrombin generation in real life clinical situations
H. C. Hemker
THROMBOSIS RESEARCH (2015)
A specific antidote for dabigatran: functional and structural characterization
Felix Schiele et al.
BLOOD (2013)
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
Jovan P. Antovic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Impact of dabigatran on a large panel of routine or specific coagulation assays Laboratory recommendations for monitoring of dabigatran etexilate
Jonathan Douxfils et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Dabigatran Etexilate A New Oral Thrombin Inhibitor
Graeme J. Hankey et al.
CIRCULATION (2011)
Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Joanne van Ryn et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Standardization and Clinical Utility of Thrombin-Generation Assays
Erik Berntorp et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Drug therapy -: Direct thrombin inhibitors
M Di Nisio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The Calibrated Automated Thrombogram (CAT):: A universal routine test for hyper- and hypocoagulability
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
分享论文
